Drug safety debates focus on proposed changes to FDA

06/5/2007 | Forbes

The drug safety debate has attracted doctors, lawyers and legislators to comment on FDA operations and proposed legislation to reform the agency. The drug industry supports the Kennedy-Enzi bill requiring more transparency for clinical trials and giving FDA added authority to change drug labels and require post-market studies. Others are calling for a separate center to monitor drugs on the market or a reformed budget to lessen industry ties.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ